Cargando…

A systematic review on the accumulation of prophylactic dosages of low-molecular-weight heparins (LMWHs) in patients with renal insufficiency

PURPOSE: Although therapeutic dosages of most low-molecular-weight heparins (LMWHs) are known to accumulate in patients with renal insufficiency, for the lower prophylactic dosages this has not been clearly proven. Nevertheless, dose reduction is often recommended. We conducted a systematic review t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Atiq, Ferdows, van den Bemt, Patricia M.L.A., Leebeek, Frank W.G., van Gelder, Teun, Versmissen, Jorie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4500846/ https://www.ncbi.nlm.nih.gov/pubmed/26071276 http://dx.doi.org/10.1007/s00228-015-1880-5

Ejemplares similares

LMWHs dosage and outcomes in acute pulmonary embolism with renal insufficiency, an analysis from a large real-world study
por: Wang, Dingyi, et al.
Publicado: (2022)

A clinically relevant pharmacokinetic interaction between cyclosporine and imatinib
por: Atiq, Ferdows, et al.
Publicado: (2016)

Effect of Low Molecular Weight Heparins (LMWHs) on antiphospholipid Antibodies (aPL) – Mediated Inhibition of Endometrial Angiogenesis
por: D'Ippolito, Silvia, et al.
Publicado: (2012)

Converting cyclosporine A from intravenous to oral administration in hematopoietic stem cell transplant recipients and the role of azole antifungals
por: Atiq, Ferdows, et al.
Publicado: (2018)

The prevention and treatment of venous thromboembolism with LMWHs and new anticoagulants
por: Blann, Andrew D, et al.
Publicado: (2009)

How I manage severe von Willebrand disease
por: Leebeek, Frank W. G., et al.
Publicado: (2019)

Feasibility of a protocol for deprescribing antihypertensive medication in older patients in Dutch general practices
por: Hassan, Dimokrat, et al.
Publicado: (2022)

Sex Differences in Spironolactone and the Active Metabolite Canrenone Concentrations and Adherence
por: Peeters, Laura E. J., et al.
Publicado: (2022)

Rosuvastatin use increases plasma fibrinolytic potential: a randomised clinical trial
por: Schol‐Gelok, Suzanne, et al.
Publicado: (2020)

Criteria for low von Willebrand factor diagnosis and risk score to predict future bleeding
por: Atiq, Ferdows, et al.
Publicado: (2021)

Clinical effects of antiplatelet drugs and statins on D‐dimer levels
por: Schol‐Gelok, Suzanne, et al.
Publicado: (2018)

The use of a clinical decision support tool to assess the risk of QT drug–drug interactions in community pharmacies
por: Berger, Florine A., et al.
Publicado: (2021)

Introducing the importance and difficulties of a three-step approach to improve nonadherence to antihypertensive drugs: a case series
por: Peeters, Laura E.J., et al.
Publicado: (2022)

Therapeutically dosed low molecular weight heparins in renal impairment: a nationwide survey
por: Jaspers, Tessa Corrine Catherina, et al.
Publicado: (2022)

Venous thrombotic events in severe and critically COVID-19 patients despite high dose prophylactic low-molecular-weight heparin
por: Visser, Chantal, et al.
Publicado: (2020)

Subcutaneous hematomas from prophylactic heparin use
por: Koratala, Abhilash, et al.
Publicado: (2017)

Anti-Xa activity after subcutaneous administration of dalteparin in ICU patients with and without subcutaneous oedema: a pilot study
por: Rommers, Mirjam K, et al.
Publicado: (2006)

Increasing dosages of low-molecular-weight heparin in hospitalized patients with Covid-19
por: Martinelli, Ida, et al.
Publicado: (2021)

Monitoring antihypertensive drug concentrations to determine nonadherence in hypertensive patients with or without a kidney transplant
por: Peeters, Laura E.J., et al.
Publicado: (2023)

Effect of renal denervation on catecholamines and the renin–angiotensin–aldosterone system
por: Feyz, Lida, et al.
Publicado: (2020)

A direct comparison of prophylactic low-molecular-weight heparin versus unfractionated heparin in neurosurgery: A meta-analysis
por: Macki, Mohamed, et al.
Publicado: (2019)

Development and validation of a tool to assess the risk of QT drug-drug interactions in clinical practice
por: Berger, Florine A., et al.
Publicado: (2020)

Association Between Workarounds and Medication Administration Errors in Bar Code-Assisted Medication Administration: Protocol of a Multicenter Study
por: van der Veen, Willem, et al.
Publicado: (2017)

Better performance of medical students on pharmacotherapy knowledge and skills tests is associated with practising with e‐learning program P‐scribe
por: Kalfsvel, Laura, et al.
Publicado: (2021)

Vascular medicine and cardio-oncology – A new, evolving clinical frontier
por: Versmissen, Jorie, et al.
Publicado: (2020)

Physicians’ acceptance of pharmacists’ interventions in daily hospital practice
por: Zaal, Rianne J., et al.
Publicado: (2020)

Ex vivo Improvement of a von Willebrand Disease Type 2A Phenotype Using an Allele-Specific Small-Interfering RNA
por: de Jong, Annika, et al.
Publicado: (2020)

Effect of a Pharmacy-based Centralized Intravenous Admixture Service on the Prevalence of Medication Errors: A Before-and-After Study
por: Jessurun, Janique G., et al.
Publicado: (2022)

Inadequate prophylactic effect of low-molecular weight heparin in critically ill COVID-19 patients
por: Stattin, K., et al.
Publicado: (2020)

Prophylactic anticoagulation with low molecular weight heparin in COVID-19: cohort studies in Denmark and Sweden
por: Lund, Lars Christian, et al.
Publicado: (2022)

Humoral response to coronavirus disease-19 vaccines is dependent on dosage and timing of rituximab in patients with rheumatoid arthritis
por: van der Togt, Céleste J T, et al.
Publicado: (2022)

HSD17B12 dosage insufficiency induced premature ovarian insufficiency in humans and mice
por: Wang, Qiqi, et al.
Publicado: (2022)

How would final‐year medical students perform if their skill‐based prescription assessment was real life?
por: Kalfsvel, Laura, et al.
Publicado: (2022)

Non-adherence to inhaled corticosteroids and the risk of asthma exacerbations in children
por: Vasbinder, Erwin C, et al.
Publicado: (2016)

A Case of Hemorrhagic Myositis Associated With Prophylactic Heparin Use in Dermatomyositis
por: Bartl, Mery, et al.
Publicado: (2023)

The effect of the COACH program (Continuity Of Appropriate pharmacotherapy, patient Counselling and information transfer in Healthcare) on readmission rates in a multicultural population of internal medicine patients
por: Karapinar-Çarkıt, Fatma, et al.
Publicado: (2010)

The role of prophylactic use of low molecular weight heparin or aspirin in thromboembolic events in primary membranous nephropathy
por: Zou, Peimei, et al.
Publicado: (2019)

Extensive Thrombosis in a Severe COVID-19 Patient Despite Prophylactic Low Molecular Weight Heparin
por: Elkattawy, Sherif, et al.
Publicado: (2020)

Dosage of heparin for patency of the totally implanted central venous catheter in cancer patients
por: de Oliveira, Francisca Jane Gomes, et al.
Publicado: (2020)

Dosage reduction of low weight heparin in patients with renal dysfunction: Effects on anti-Xa levels and clinical outcomes
por: Hornung, Paul, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_t2e3hh24hth1vipmhqegdu8df8